Brexit Effect on Biosimilars

The Brexit effect on Biosimilars tends to be negative. Not only would it be a major setback towards approval and launch of biosimilars to the market but also it would be hindrance towards the cost cutting approach taken up by NHS. With Britain being among principal clinical trial centers is owned to see a decrease in the willingness of the manufacturers and researchers to carry out any further trials in Britain. Also Brexit will cause the principal motive of British Biosimilars Association (BBA) to fall back- which aimed at increasing the use of biosimilars.

 

    Related Conference of Brexit Effect on Biosimilars

    December 05-06, 2024

    27th World Congress on Nursing, Pharmacology and Healthcare

    Paris, France
    December 12-13, 2024

    12th International Conference and Exhibition on Natural Products and Medicinal Plants Research

    Rome, Italy
    January 06-07, 2025

    29th Annual Meeting on Pharmaceutical Biotechnology

    London, UK
    February 24-25, 2025

    2nd International Conference on Pharmacognosy

    Madrid, Spain
    February 27-28, 2025

    8th International on Pharmacy and Pharmaceutical Conference

    Prague, Czech Republic
    March 10-11, 2025

    35th Annual European Pharma Congress

    Rome, Italy
    April 07-08, 2025

    4th International Conference and Expo on Pharmaceutics & Novel Drug Delivery Systems

    Vancouver, Canada
    April 14-15, 2025

    18th European Biosimilars Congress

    Paris, France
    April 24-25, 2025

    18th World Drug Delivery Summit

    London, UK
    May 05-06, 2025

    21st International Conference on Pharmaceutical Chemistry

    Rome, Italy
    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    May 05-06, 2025

    17th International Conference on Pharmaceutical Education and Practice

    Vancouver, Canada
    May 19-20, 2025

    7th International Conference and Exhibition on Pain Management

    Zurich, Switzerland
    May 19-20, 2025

    16th Annual Congress on Bioavailability and Bioequivalence

    Rome, Italy
    June 02-03, 2025

    31st International Conference on Advanced Clinical Research and Clinical Trials

    Amsterdam, Netherlands
    June 10-11, 2025

    24th International Conference on Medicinal and Pharmaceutical Chemistry

    Vancouver, Canada
    June 10-11, 2025

    7th International Conference and Exhibition on Pharmaceutical Development and Technology

    Vancouver, Canada
    June 16-17, 2025

    18th International Conference and Exhibition on Pharmacovigilance & Drug Safety

    Frankfurt, Germany
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    25th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry

    Paris, France
    June 23-24, 2025

    27th International Congress on Pharmaceutical Biotechnology Research

    Paris, France
    July 24-25, 2025

    5th World Congress on Cardiovascular Medicine Pharmacology

    Paris, France
    September 08-09, 2025

    26th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems

    Frankfurt, Germany
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    October 22-23, 2025

    7th European Conference on Advance Clinical Trials and Research

    Paris, France
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Brexit Effect on Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in